Printer Friendly

NEW MEMBER APPOINTED TO IVAX BOARD OF DIRECTORS

 NEW MEMBER APPOINTED TO IVAX BOARD OF DIRECTORS
 MIAMI, Feb. 24 /PRNewswire/ -- IVAX Corporation (AMEX: IVX)


announced today that its board of directors appointed Harold S. Geneen as a new member of the board. Geneen was formerly the chairman of the board of directors of International Telephone and Telegraph Corporation. Geneen is a member of the board of trustees of the Salk Institute and the board of governors of the School of Medicine of the University of Miami and has served in various community associations, including chairman of the National Alliance of Businessmen and National Chairman of the United States Industrial Payroll Savings Program. For his efforts in the area of international business, Geneen has received the order Commander of the Order of the Crown from Belgium, the order of Merit for Distinguished Service from Peru, and the Grand Cross of Isabella from Spain.
 IVAX Corporation is a holding company with subsidiaries involved in specialty chemicals, pharmaceuticals and medical diagnostics. IVAX' principal subsidiaries include Baker Cummins Pharmaceuticals, Inc., a developer and marketer of unique brand name pharmaceuticals; Norton Healthcare Limited, a leading manufacturer and marketer of off-patent pharmaceuticals in the United Kingdom, Ireland and other countries; Goldline Laboratories, Inc., a national marketer of off-patent prescription and over the counter pharmaceuticals in the United States; Best Generics, Inc., a national distributor of off-patent pharmaceuticals in the United States; Baker Cummins Dermatologicals, Inc., a dermatological products company; Diamedix Corporation, a medical diagnostics company; Delta Biologicals S.r.l., a marketer of medical diagnostic tests and instruments in Italy; and IVAX Industries, Inc., a chemical specialties business.
 -0- 2/24/92
 /CONTACT: Richard C. Pfenniger Jr., senior vice president of legal affairs of IVAX Corporation, 305-590-2309/
 (IVX) CO: IVAX Corporation ST: Florida IN: MTC SU: PER


SS-JJ -- FL004 -- 1759 02/24/92 09:34 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 24, 1992
Words:302
Previous Article:PMC CAPITAL REPORTS EARNINGS
Next Article:WISCONSIN PHARMACAL ELECTS ROBERT E. BELLIN AND TOD R. HULLIN TO BOARD OF DIRECTORS
Topics:


Related Articles
DANTE FASCELL APPOINTED TO IVAX BOARD OF DIRECTORS
ANDRX ANNOUNCES NEW BOARD MEMBERS
IVAX ANNOUNCES RESULTS OF ANNUAL MEETING AND PROMOTION OF DR. JOHN K. WHISNANT
IVAX JOINS FORTUNE 500; EXPANDS MANAGEMENT TEAM
IVAX ANNOUNCES KEY MANAGEMENT APPOINTMENTS AT BAKER NORTON PHARMACEUTICALS
IVAX ANNOUNCES KEY MANAGEMENT APPOINTMENTS AT BAKER NORTON PHARMACEUTICALS
IVAX CORPORATION APPOINTS DR. SAMUEL BRODER AS CHIEF SCIENTIFIC OFFICER
Bergen Brunswig and IVAX Sign $3.2 Billion Definitive Merger Agreement
IVAX Corporation Appoints Robert C. Strauss as President and Chief Operating Officer
Dr. Rafick G. Henein Named President and CEO Of IVAX Subsidiary Zenith Goldline Pharmaceuticals

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters